High endo180 receptor expression in mammary and colorectal CAFs also correlates with an elevated fibroblast TGFβ response signature that is associated with poor outcome in several cancers, including prostate cancer [161,172,173,174]. This evidence concerns the gene TGFB1 and prostate carcinoma.